Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,581
Closed -$202K 1430
2025
Q4
$202K Buy
7,581
+650
+9% +$19.2K ﹤0.01% 1323
2025
Q3
$210K Sell
6,931
-655
-9% -$19.9K ﹤0.01% 1228
2025
Q2
$238K Buy
7,586
+2,157
+40% +$71.3K 0.01% 1056
2025
Q1
$207K Sell
5,429
-2,961
-35% -$126K 0.01% 1016
2024
Q4
$368K Buy
8,390
+1,538
+22% +$67.5K 0.01% 756
2024
Q3
$295K Buy
6,852
+295
+4% +$13.1K 0.01% 766
2024
Q2
$296K Buy
6,557
+418
+7% +$21.7K 0.01% 777
2024
Q1
$383K Sell
6,139
-2,669
-30% -$160K 0.02% 631
2023
Q4
$493K Buy
8,808
+742
+9% +$37K 0.03% 537
2023
Q3
$425K Buy
+8,066
New +$470K 0.03% 496

Other funds holding ENOV

MGO One Seven's ENOV Position: Q1 2026 in Review

MGO One Seven sold out of Enovis (ENOV) in Q1 2026, closing a stake of 7,581 shares — an estimated $202K sold.

MGO One Seven first reported a position in ENOV in Q3 2023 and held it in 10 quarters. The position peaked at $493K in Q4 2023. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • MGO One Seven reported no remaining Enovis position as of Q1 2026 after selling out during the quarter.
  • MGO One Seven sold 7,581 Enovis shares in Q1 2026, an estimated $202K.
  • MGO One Seven first reported a position in Enovis in Q3 2023 and held it in 10 quarters.
  • MGO One Seven's Enovis position peaked at $493K in Q4 2023.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.